Febuxostat induced Stevens Johnson syndrome: A case report.

IF 0.9 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE Pub Date : 2024-11-01 Epub Date: 2024-11-05 DOI:10.1177/09246479241292014

Jaspreet K Sidhu, Deepti Chopra

引用次数: 0

Abstract

Background: Febuxostat is a novel non-purine selective xanthine oxidase inhibitor with superior ability to lower serum urate levels than allopurinol.Case Report: We report a case of Stevens Johnson syndrome following febuxostat administration.Conclusion: This case report underlines the necessity of recognising this major mucocutaneous adverse reaction and the need for cautious medication usage.

查看原文本刊更多论文

非布司他诱发史蒂文斯约翰逊综合征1例报告。

背景：非布司他是一种新型的非嘌呤选择性黄嘌呤氧化酶抑制剂，具有比别嘌呤醇更强的降低血清尿酸水平的能力。病例报告：我们报告一个病例史蒂文斯约翰逊综合征后非布司他的管理。结论：本病例报告强调了认识这一主要粘膜皮肤不良反应的必要性和谨慎用药的必要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

2.20

自引率

17.60%

发文量

102

期刊介绍： The International Journal of Risk and Safety in Medicine is concerned with rendering the practice of medicine as safe as it can be; that involves promoting the highest possible quality of care, but also examining how those risks which are inevitable can be contained and managed. This is not exclusively a drugs journal. Recently it was decided to include in the subtitle of the journal three items to better indicate the scope of the journal, i.e. patient safety, pharmacovigilance and liability and the Editorial Board was adjusted accordingly. For each of these sections an Associate Editor was invited. We especially want to emphasize patient safety.